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Targeted transgenic mouse models, where an exogenous gene is inserted into a speciﬁed genomic
locus to achieve its stable and reliable expression, have been widely used in biomedical research.
However, the available methodologies for targeted insertion of sequences require many laborious
steps that involve the use of embryonic stem (ES) cells. We recently developed Pronuclear
Injection-based Targeted Transgenesis (PITT), a method that uses a recombinase-mediated cassette
exchange (RMCE) to enable insertion of sequences at a predetermined genomic locus, such as
ROSA26. The PITT technique uses fertilized eggs (instead of ES cells) collected from ‘seed mice’ that
contain the RMCE landing pad. The PITT method can rapidly generate reliable targeted transgenic
mice; it requires a seed mouse, which in our previous study was generated using ES cell targeting
approaches. Here, we demonstrate that seed mice containing the RMCE landing pad can be devel-
oped rapidly by using the CRISPR/Cas9 system. One of the CRISPR targets tested in this study enabled
the insertion of sequences precisely at the original ROSA26 provirus integration site. We anticipate
that using a similar approach, PITT landing pad sequences can be rapidly and precisely inserted at
other genomic loci to develop an array of PITT tools. This two-step strategy combines the best fea-
tures of the two newer technologies—rapid creation of PITT landing pads using the CRISPR/Cas9 sys-
tem and efﬁcient and precise insertion of larger cassettes at the landing pads using PITT. This study
also revealed that anomalous and mosaic sequence insertions can occur with the CRISPR/Cas9
system.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
To date, the transgenic mice generation process largely uses a
method in which the DNA is injected into fertilized eggs
(pronuclei). Even though the pronuclear injection (PI) method is
quite efﬁcient in generating multiple transgenic lines, the integra-
tion of the DNA at random places in the genome poses many prob-
lems—the transgene may not express if it gets integrated in an
inactive chromatin region, multiple tandem copy integration can
lead to subsequent inactivation of the transgene, and inadvertentintegration of the transgene in a region that codes for important
genes might disrupt their function. Because of such reasons, typi-
cally many independent transgenic lines are screened through
strenuous and time taking steps of breeding them to identify the
best suited line for further experiments.
To overcome the pitfalls of random transgenesis, certain labs
have taken the embryonic stem (ES) cell approach to target a single
copy of a transgene into well-studied genetic loci, such as ROSA26.
However, this approach involves laborious and time-consuming
steps, such as targeting vector construction, ES cell targeting,
screening and expansion of correctly targeted clones, chimera
generation and breeding them for germ line transmission.
Despite the lengthy and expensive process that takes 7–8 months
or longer, success is not guaranteed [3] and not surprisingly, this
method is not routinely used.
Recently, we and others have developed a targeted transgenesis
method through direct injection of DNA into pronuclei [7,6,5]. This
method, termed pronuclear injection-based targeted transgenesis
192 R.M. Quadros et al. / FEBS Open Bio 5 (2015) 191–197(PITT), involves prior development of a seed mouse that harbors
landing pads for recombinase-mediated cassette exchange
(RMCE) at a predetermined locus. In the Cre-Lox system-based
PITT (Cre-PITT) that we developed the landing pad constituted het-
erotypic LoxP sites (JT15 and Lox2272) that allow uni-directional
and precise exchange of the DNA cassettes from specially designed
donor vectors containing compatible mutant LoxP sites for RMCE.
Unlike the ES cell based approaches, the PITT approach takes about
3–4 months and provides considerable savings with respect to
time and expense. However, this method uses a previously
established PITT seed strain, which is usually generated through
a traditional ES cell-based approach [6,7,10].
In this work, we sought to explore options to generate a PITT
seed mouse faster by directly inserting heterotypic LoxP sequences
into the mouse ROSA26 locus using Clustered Regularly Interspaced
Short Palindromic Repeats (CRISPR)/CRISPR-associated 9 (Cas9)
system. Our aim was to create a ‘‘simpler’’ seed mouse that would
only contain essential elements for PITT and leave out nonessential
elements such as a PGK-neomycin-polyA signal sequence that were
necessary in the previous seed strain [7]. In addition, such a seed
mouse would enable the insertion of larger cassettes through
RMCE, in the next step. This two-step approach could be easily
applied to other chromosomal locations that will circumvent the
necessity to construct larger homology-arm containing plasmid
vectors as required for ES cell based, or one-step CRISPR/Cas9-based
approaches.
2. Materials and methods
2.1. Plasmids
The pBGK plasmid described in [2] was used as a template for
Cas9 mRNA synthesis. pUC57-sgRNA expression vector (Addgene
plasmid 51132; [8] was used as vector to clone sgRNA sequences
that includes T7 promoter, convenient BsaI cloning sites for cloning
of annealed sgRNA oligonucleotides and a DraI site for
linearization.
2.2. Synthesis and puriﬁcation of Cas9 mRNA and sgRNAs and donor
oligos
The oligos corresponding to Cr2 and Cr4 sgRNAs were cloned
into BsaI site of pUC57-sgRNA expression vector [8]. The positive
clones were sequence conﬁrmed and used for in vitro transcription
of sgRNA. The Cas9 mRNA was transcribed from pBGK plasmid that
was created by replacing iCre coding sequence with Cas9 in the
pBBI vector [5] (Supplementary Fig. 1). The pBGK plasmid contains
a stretch of 83 ‘A’s after the stop codon; this feature enables the
direct synthesis of polyA containing mRNA and therefore the
in vitro transcribed RNA does not require additional a poly-adenyla-
tion step. Linearized pBGK Cas9 by XbaI digestion was gel puriﬁed
and used as the template for in vitro transcription using
mMESSAGE mMACHINE T7 ULTRA kit (Ambion: AM 1345). The
sgRNAs were synthesized using MEGAshortscript T7 kit (Ambion:
AM 1354) from DraI linearized pUC57 vector templates. Both type
of RNAs were puriﬁed using MEGAclear kit (Ambion: AM 1908)
and eluted in RNase-free water. Single-stranded DNA Donors were
purchased as Ultramer DNA oligos from Integrated DNA
Technologies.
2.3. Pronuclear injection
B6/SJLF2 hybrids were used as embryo donors. Detailed descrip-
tion of CRISPR/Cas9-mediated mouse genome editing are described
in [2]. Brieﬂy, the injection mix contained 10 ng/ul ofsgRNAs + 10 ng/ul of Cas9 mRNA. Donor oligo concentration
included in some experiments was 20 ng/ul. We followed
simultaneous cytoplasmic and nuclear injection method as
described in [5]. The care, use, and disposition of animals used in
this study were approved by the Institutional Animal Care and
Use Committee of the University of Nebraska Medical Center.
2.4. Genotyping of offspring and nucleotide sequencing
Genomic DNAs extracted from the offspring using Qiagen
Gentra Puregene Tissue Kit were subjected to ﬂanking primer
PCR and internal (the donor oligo speciﬁc) and external primer
PCR. Surveyor assay was performed as described by the manufac-
turer (Transgenomic). The primers used for amplifying the target
sequence are given in the Supplementary Table 1. The assay prod-
ucts were analyzed using a 2.5% agarose gel. The bigger sized bands
in ﬂanking PCR genotyping assay of selected samples were gel pur-
iﬁed and were subjected to direct sequencing. The upper bands of
sample 6 (from internal + external PCR assay) and sample 23
(ﬂanking PCR assay) were cloned into pCR 2.1 Topo cloning vector
(Invitrogen: Cat # K4560) and the plasmids were sequenced using
M13 Forward primer.
2.5. Off-target analysis
All potential off-target sites with homology to the 23 bases
sequence (sgRNA target + PAM) were retrieved by a base-by-base
scan of the whole genome, allowing for ungapped alignments with
up to 5 mismatches in the sgRNA target sequence. The off-target
sites were ampliﬁed using primers binding to ﬂanking regions
and were subjected to Surveyor assay.3. Results
3.1. Designing of ROSA26-CRISPR target sequences
CRISPR target sequences in the ﬁrst intron of mouse ROSA26
locus, the site where majority of the ROSA26 knock-in mutations
have been created, were searched through UCSC browser http://
www.genome-engineering.org/crispr/?page_id=41 (Fig. 1A). The
target sequences were numbered ROSA-Cr 1 to 4. (ROSA-Cr1 is
270 base upstream of the XbaI site and ROSA-Cr2 to 4 are located
62 to 248 bases downstream of the XbaI site (Fig. 1B). We intended
to test two independent CRISPR target sites: one that is immedi-
ately downstream of XbaI site; the most commonly used site for
inserting transgenes and the second one close to the original pro-
viral integration site. Among the ROSA-Cr1 to 4 target sites, Cr2
and Cr4 sites met these criteria and therefore were chosen for
CRISPR/Cas9 mutagenesis experiments. The Cr4 site cleaves exactly
at the original provirus integration site [9,1].
3.2. Targeted insertion of heterotypic LoxP sites at the ROSA26-CRISPR
targets and genotyping of offspring
We designed experiments to insert short sequences at Cr2 and
Cr4 target sites using oligonucleotide assisted homology directed
repair process. These short single-stranded DNA donors contained
60 bases of homology on both the ends and two heterotypic LoxP
sites (JT15 and lox2272) in the middle. The objective of choosing
such an oligo design was to create a PITT seed mouse that can
eventually be used for insertion of larger transgenes at the
ROSA26 locus using Cre-PITT. Microinjection of CRISPR components
were performed as described in Materials and Methods section and
the microinjection data is compiled in Table 1.
A 
B 
Fig. 1. CRISPR target sequences in the ROSA26Sor locus. The CRISPR target sequences in the ﬁrst intron of ROSA26 locus were searched through the UCSC genome browser
available through genome-engineering.org/tools (Zhang lab). The results displayed 14 target sequences, of which 4 were within the vicinity of 270 bases from the XbaI site,
the most commonly used site for targeted insertion of foreign sequences at this locus. These four target sites were named as ROSA Cr1, Cr2, Cr3 and Cr4 and only the Cr2 and
Cr4 sites were tested in this study. The cut sites are indicated by a forward slash (/) and PAM sequences are underlined.
Table 1
Microinjection data.
sgRNA Embryos injected Embryos transferred # fosters used # pregnant fosters Animal id numbers (total) Oligo insertion (%)
Cr2 108 98 5 3 1–5, 18–36, 47–55 (33) 11 (33%)
Cr4 87 67 4 3 6–17, 37–46 (22) 8 (36%)
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ampliﬁed using ﬂanking primers and analyzed in a 2% agarose
gel. As expected, some samples had slower migrating bands indica-
tive of donor oligonucleotide insertion (Fig. 2A). While there were
many founders that had the expected increase in size, some (foun-
ders 6, 9, 14, 15, 16, 20 and 23) had higher than the expected sized
bands (Fig. 2A). The higher sized (or incorrect sized bands) may be
the result of scenarios such as (i) addition of more than one copy of
the donor-oligo, or (ii) duplication of some adjacent sequences
near the target site before the donor-oligo gets inserted, or (iii)
combination of varying lengths of deletion & addition ofnucleotides followed by insertion of the donor-oligo, or (iv) due
to unequal ampliﬁcation of templates (higher sized bands being
less favored) in the PCR reaction.
We further analyzed the samples by a PCR using an internal pri-
mer that binds to the donor-oligo sequence and an external primer
that binds outside the homology arms. In this ‘internal + external
primer PCR’ assay, a band is detected only if there is an insertion
of the donor-oligo at the cleavage site. As expected, most of the
samples that showed higher migrating bands in the ‘ﬂanking pri-
mer PCR’ assay were positive for PCR using this primer set
(Fig. 2B). Collective results from the two different types of
A. Flanking Primer PCR Genotyping B. Internal+External Primer PCR Genotyping 
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Fig. 2. Genotyping of offspring. (A) Schematic of Flanking Primer PCR assay. The primers bind on the ﬂanking sequences. Insertion of the JT15-Spacer-Lox2272 sites adds 78
bases at the target site that increases the PCR band size from 419 bp (wild type) to 497 bp (mutant). Some samples show incorrect sized mutant band (see text for details). (B)
Internal + External primer PCR. Genotyping PCR with a forward primer in the repair oligo region and a reverse primer downstream of Cr4 site. Insertion at Cr2 and Cr4 sites
will yield bands of 410 and 225 base pairs respectively. See text for discussion on results for samples 6 and 53. M: 100 base pair Marker.
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of offspring had targeted insertion of donor-oligo at Cr2 and Cr4
sites respectively. Interestingly, two samples (# 6 and # 53)
showed two bands (instead of expected one band) in this PCR;
these results are discussed further (see below).
Higher migrating sharper bands from ﬂanking PCR assay for a
few samples were puriﬁed and sequenced. While some samples
showed clean sequence (Fig. 3A) with precise insertion of the
donor-oligo sequence, others contained mixtures of sequences
indicative of mosaicism (data not shown), possibly due to inser-
tions occurring after the 2 cell stage [4]. Since we obtained more
than sufﬁcient number of founders with the precise oligo sequence
insertion, we only bred two founders each (for Cr2 or Cr4 inser-
tions) from these and we did not pursue breeding of the other
founders. Out of curiosity, we further analyzed the nature of
mutations in a few samples that showed atypical banding pattern
in the genotyping PCRs. The results uncovered some anomalous
mutations in those samples that are presented below.
3.3. Occurrence of anomalous and/or mosaic insertions of donor-oligo
in CRISPR/Cas9-mediated genome editing
In the ‘internal + external primer PCR assay’, the sample 6
showed one expected sized band and another unexpected sized
(larger) band. Notably, this sample did not amplify a wild type
band in the ﬂanking PCR but there were two faint and diffused lar-
ger sized bands (Fig. 2B). The lack of wild type sized band indicates
that both alleles may have got mutated with a possibility of loss of
sequences near the forward primer binding site. We cloned and
sequenced the larger sized band (from internal + external primer
PCR) which revealed an anomalous insertion event—there was a
stretch of 87 extra nucleotides inserted upstream of the correctlyinserted donor cassette of 78 nucleotides. This 87 nucleotide extra
sequence constituted (i) duplication of 59 nucleotides immediately
upstream of the cleavage site followed by (ii) a 26 base long
inverted sequence originated from the 7 to 32 nucleotides down-
stream of the cut site and (iii) two nucleotides (insertion) of
unknown origin (Fig. 4C and D). It is difﬁcult to ascertain how such
a donor event must have occurred, but it clearly indicates that
anomalous insertions of donor-oligos can occur in CRISPR/Cas9-
mediated genome editing.
The mutant amplicon (upper band) in the ﬂanking primer PCR
assay of the sample 23 was higher size than the anticipated
increase of 78 bases (size of the donor template) from the wild
type. We cloned and sequenced the upper band, which revealed
an insertion of a stretch of extra 84 nucleotides of a random mix
of various short fragments—8 nucleotides of unknown origin, 22
nucleotides of inverted sequence originated from immediately-
downstream of the Cr2 cut site followed by desired insertion cas-
sette with one nucleotide mismatch and one nucleotide deletion,
30 nucleotides of unknown origin and partial Lox2272 sequence
of 25 nucleotide long (Fig. 4G and H).
Even though the sample 53 showed two bands in the inter-
nal + external primer PCR, it did not show a higher migrating band
in the ﬂanking primer PCR assay (Fig. 2A). This indicates the
possibility that this founder constitutes at least three alleles (a wild
type allele detected in ﬂanking PCR assay and two different mutant
alleles detected by internal + external primer PCR assay) and there-
fore should contain mosaic mutations. It is also likely that the wild
type template would have preferentially been ampliﬁed (in the
ﬂanking PCR assay) because of its relative abundance in the mosaic
genomic DNA and the mutant bands might not have got ampliﬁed.
Another reason for the absence of mutant bands (larger sized
bands in ﬂanking PCR assay) could be that the forward primer
GLT Rosa Cr For + Rev 
    M       Het    WT     WT      WT    Hom  Hom    WT    WT 
Wild Type:  249bp 
Het:  249bp + 327bp 
Homo:  327 bp 
Internal F + FlankingR 
   M    Het      WT     WT    WT    Hom  Hom    WT    WT 
Wild Type:      No Product 
Het or Homo:  225 bp 
JT 15 Lox2272 
Cr4 cut site 
 
Fig. 3. Germ line transmission and establishment of a homozygous Cr4 insertion mutation. (A) A sequencing reaction chromatogram from a founder mouse showing a correct
donor-oligo insertion at the Cr4 target site. (B) The sequence conﬁrmed mutant was bred with a wild type mouse and germ line transmission was established. Genotyping of
F2 generation litter with ﬂanking primers PCR (left) and with Internal + External primers PCR (right). The expected product sizes and the genotypes are given below the gel
images. M: 100 base pair Marker. (C) Nucleotide sequence of the locus containing the correct insertion sequence. The locations of primers are shown with the corresponding
color coded arrows. Cr4 sequence is underlined and PAM sequence is shown in uppercase.
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ple. We sequenced the upper band from the internal + external PCR
reaction. Although, the direct sequencing of the gel puriﬁed PCR
product did not yield a quality sequencing reaction to clearly iden-
tify the extra sequence and its exact length, the results were
indicative of anomalous insertion event (data not shown).
Another sample indicative of mosaic mutant pattern is #16 that
contains one prominent wild type, and two minor bands (one band
much larger than- and the other smaller than- the wild type).
Taken together, the results from the analysis of the extra bands
in the ‘internal + external primer PCRs’ and atypical bands in
‘ﬂanking primer PCRs’ revealed that anomalous insertions and
mosaic mutations occur in CRISPR/Cas9-mediated genome editing
experiments that include donor-oligo insertion designs.
Two founders each harboring insertions at Cr2 or Cr4 sites, that
were sequence-conﬁrmed, were mated to achieve germ line trans-
mission of the mutation. The schematic of genotyping assays and a
representative gel images showing the germ line transmission for a
litter from Cr4 insertion site are shown in Fig. 3B. Since the Cr4 site
is located precisely at the original pro-viral integration site, we rea-
soned that Cr4 site mutants would be preferred over the Cr2 site to
use them as PITT seed strain for future studies and therefore, we
veriﬁed if there were any off-target cleavages in any of the eight
Cr4 mutant animals. Seven potential off-target sites of Cr4 target
sequence were identiﬁed in the mouse genome and a surveyor
assay was performed at all these off-target sites in all of the eight
Cr4 positive animals. We did not observe off-target Cas9 activity in
any animals at any of the 7 potential off-target sites, as indicated
by lack of cleavage products in the surveyor assay
(Supplementary Fig. 2).4. Discussion
Traditionally, insertion of transgenes at a predetermined site in
the mouse genome has been achieved through laborious and
time-consuming steps such as targeting vector construction, ES cell
targeting, screening and expansion of correctly targeted clones,
chimera generation and breeding them for germ line transmission.
Using such approaches several transgenes have been targeted to
the ROSA26 locus in the mouse genome. During the recent 3–
4 years, we and others have shown that all of the steps involved
in traditional targeted transgenesis method can be bypassed using
the newly developed PITT system [7,10,6,5]. PITT involves prior
development of a seed mouse that has heterotypic LoxP sites called
landing pads at the genomic locus of interest. In the second step,
viz. PITT, the fertilized eggs from the seed mouse are used for
injecting a donor plasmid containing the transgenic cassette of
interest along with Cre mRNA which results in precise insertion
of the transgenic cassette at the landing pad. In this report, we
tested if a PITT seed mouse can be created at the ROSA26 locus
by co-injecting ROSA sgRNA (either ROSA-Cr2 or ROSA-Cr4 sites),
Cas9 mRNA and a donor-oligo into fertilized eggs. We reasoned
that by using CRISPRs, just the LoxP sites required for the PITT seed
mice can be inserted, without any additional sequences such as a
neomycin cassette as needed in the traditional ES cell approach.
The mutant mouse so created would serve as a seed mouse for
future PITT experiments to insert larger sequences using the Cre-
Lox-based Recombinase-Mediated Cassette Exchange (RMCE)
mechanism [7,6]. Upon publication, the new seed mouse strain will
be made available to the research community which could be used
for precise insertion of desired transgenes through PITT.
Fig. 4. Examples of anomalous sequence insertions occurring during HDR mediated CRISPR/Cas9 genome editing events. Nucleotide sequence after the expected donor-oligo
insertion at the ROSA-Cr4 site (A), and its schematic (B). Schematic of anomalous insertion in the sample #6 (C), and its nucleotide sequence (D). Nucleotide sequence after
the expected donor-oligo insertion at the ROSA-Cr2 site (E), and its schematic (F). Schematic of anomalous insertion in the sample # 23 (G) and its nucleotide sequence (H).
The schematics include blue (left) or red (right) bars and the nucleotide numbering include ‘‘’’ (left) or ‘‘ + ’’ (right) signs that demarcate the Cas9 cut sites. The stretches of
extra sequences (in D and H) are highlighted with corresponding (blue or red) color to indicate their origin. All LoxP sequences are highlighted in yellow and boxed except the
partial LoxP site (in H), which is only highlighted and not boxed. The sequences originating from unknown origin are boxed and are not highlighted with any color (in D and
H).
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locus, we noted that the ROSA-Cr4 site is exactly where the initial
provirus mediated LacZ insertion was characterized [9,1]. We rea-
soned that if the Cr4 target site can be validated to insert
sequences using the CRISPR/Cas9 system, it may be a better target-
ing approach, unlike the available targeting vector tools that are
designed to insert sequences at the XbaI site which is 248 bases
upstream of the provirus integration (/Cr4) site. As demonstrated
in this work, exogenous sequences can be inserted precisely at
the original provirus insertion site using the CRISPR/Cas9 system
(Fig. 2C). The short stretch of sequences (mutant LoxP sites)
inserted in this work serves as a landing pad for PITT method using
which larger cassettes can be inserted into the landing pad. The
PITT technique can typically insert 8–10 kb long cassettes and
the largest DNA piece inserted so far is 14.4 kb [5].
Mosaicism and allele complexities have been reported in gene
disruption experiments using CRISPR/Cas9 system [4,11]. Li et al.,
in their ‘Th’ locus disruption experiment, reported that as many
as six different mutations were detected in the offspring when
a founder was bred even when they could only identify two
mutant alleles in the founder [4]. Yen et al., readily detected
somatic mosaicism and allele complexities in their experiment
which targeted the tyrosinase (Tyr) gene in C57BL/6 mice that
resulted in albino as well as patchy coat colored offspring and
the co-existing mutations were segregated when the founders
were bred [11]. While these reports have observed mosaicism
and allele complexities in Non-Homologous End Joining (NHEJ)-
mediated CRISPR/Cas9 genome editing experiments, our report
presents evidence that anomalous insertions and mosaicism can
occur in Homology Directed Repair (HDR)-mediated CRISPR/
Cas9 genome editing experiments.As noted in the results section, we only sequenced the alleles of
a few founders that appeared to contain atypical genotyping pat-
tern. A comprehensive analysis of multitude of mutant alleles
among the founders in a CRISPR/Cas9 mutagenesis experiment
may be of scientiﬁc interest to understand the nature of HDR
mechanism that occur during Cas9 cleavage. Such analysis can be
done by systematically breeding many F0 founders to segregate
multiple alleles and analyzing multiple different mutations among
a library of offspring from each founder.
In summary, this work validates the CRISPR target sequences at
ROSA26 locus, the most commonly used genetic locus in mouse for
targeted knocking-in of exogenous sequences. Furthermore, the
model created using the CRISPR/Cas9 system will serve as a simpli-
ﬁed PITT seed mouse that can be used to insert larger cassettes
through RMCE, similar to the previously generated seed mice.
The two-step strategy—introducing heterotypic LoxP sites using
CRISPR/Cas9 system and then inserting larger cassettes through
PITT approach offers two distinct advantages; i) it overcomes the
current limitations of the two techniques—the lengthy and expen-
sive steps of creating a seed mouse needed for the PITT technique
and relative inefﬁciency of CRISPR/Cas9 system to readily and pre-
cisely insert larger cassettes and ii) it combines the best features of
the two new techniques—CRISPR/Cas9 system assisted rapid cre-
ation of PITT seed mice by targeted insertion of a landing pad at
a desired locus and the capability of PITT system to precisely insert
larger DNA cassettes into the landing pad. The two-step strategy
(introducing heterotypic LoxP sites using CRISPR/Cas9 system
and then inserting larger cassettes), can also be applied to other
chromosomal locations and may circumvent the necessity to con-
struct larger homology containing plasmid vectors as required for
ES cell-based or one-step CRISPR/Cas9-based strategies.
R.M. Quadros et al. / FEBS Open Bio 5 (2015) 191–197 197Authors’ contributions
CBG conceived the study. CBG and MO designed the study. RMQ
and DWH performed pronuclear injections, mouse breeding
experiments and acquired the data. RMQ and CBG performed geno-
typing assays. CBG and MO analyzed and interpreted data and
wrote the manuscript. All authors read and approved the ﬁnal
manuscript.
Acknowledgements
This work was partially supported by an Institutional
Development Award (IDeA) to CBG (PI: Shelley Smith) from the
National Institute of General Medical Sciences of the National
Institutes of Health under grant number P20GM103471 to CBG,
by Grant-in-Aid for Scientiﬁc Research (25290035) from the
Ministry of Education, Culture, Sports, Science and Technology
(MEXT), and 2014 Tokai University School of Medicine Research
Aid to MO. We thank Bin Shen and Xingxu Huang for providing
pUC57-sgRNA vector and for valuable suggestions on the manu-
script. We thank Manju George for critical reading of the manu-
script and for English corrections. We thank Ronald Redder and
Gregory Kubik, UNMC DNA sequencing core facility for their help
with sequencing. The DNA Sequencing Core receives partial sup-
port from the NCRR (1S10RR027754-01, 5P20RR016469,
RR018788-08) and the National Institute for General Medical
Science (NIGMS) (8P20GM103427, P20GM103471). RMQ, DWH
and CBG acknowledge the Nebraska Research Initiative and
UNMC Vice Chancellor for Research Ofﬁce for supporting the
mouse genome engineering core facility. MO acknowledges the
people in Support Center for Medical Research and Education in
Tokai University for technical assistance.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.fob.2015.03.003.References
[1] Friedrich, G. and Soriano, P. (1991) Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice. Genes
Dev. 5, 1513–1523.
[2] D.W. Harms, R.M. Quadros, D. Seruggia, M. Ohtsuka, G. Takahashi, L. Montoliu,
C.B. Gurumurthy, 2014. Mouse Genome Editing Using the CRISPR/Cas System.
Current Protocols in Human Genetics/Editorial Board, Jonathan L. Haines,
[et al.] 83:15.7.1–15.7.27.
[3] Lee, A.Y. and Lloyd, K.C.K. (2014) Conditional targeting of Ispd using paired
Cas9 nickase and a single DNA template in mice. FEBS Open Biol. 4, 637–642.
[4] Li, D., Qiu, Z., Shao, Y., Chen, Y., Guan, Y., Liu, M., Li, Y., Gao, N., Wang, L., Lu, X.,
et al. (2013) Heritable gene targeting in the mouse and rat using a CRISPR-Cas
system. Nat. Biotechnol. 31, 681–683.
[5] Ohtsuka, M., Miura, H., Hayashi, H., Nakaoka, H., Kimura, M., Sato, M.,
Gurumurthy, C.B. and Inoko, H. (2013) Improvement of pronuclear injection-
based targeted transgenesis (PITT) by iCre mRNA-mediated site-speciﬁc
recombination. Trans. Res. 22, 873–875.
[6] Ohtsuka, M., Miura, H., Sato, M., Kimura, M., Inoko, H. and Gurumurthy, C.B.
(2012) PITT: pronuclear injection-based targeted transgenesis, a reliable
transgene expression method in mice. Exp. Anim./Jpn. Assoc. Lab. Anim. Sci.
61, 489–502.
[7] Ohtsuka, M., Ogiwara, S., Miura, H., Mizutani, A., Warita, T., Sato, M., Imai, K.,
Hozumi, K., Sato, T., Tanaka, M., et al. (2010) Pronuclear injection-based mouse
targeted transgenesis for reproducible and highly efﬁcient transgene
expression. Nucl. Acids Res. 38, e198.
[8] Shen, B., Zhang, W., Zhang, J., Zhou, J., Wang, J., Chen, L., Wang, L., Hodgkins, A.,
Iyer, V., Huang, X., et al. (2014) Efﬁcient genome modiﬁcation by CRISPR-Cas9
nickase with minimal off-target effects. Nat. Methods 11, 399–402.
[9] Soriano, P. (1999) Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Gene. 21, 70–71.
[10] Tasic, B., Hippenmeyer, S., Wang, C., Gamboa, M., Zong, H., Chen-Tsai, Y. and
Luo, L. (2011) Site-speciﬁc integrase-mediated transgenesis in mice via
pronuclear injection. Proc. Natl. Acad. Sci. U.S.A. 108, 7902–7907.
[11] Yen, S.-T., Zhang, M., Deng, J.M., Usman, S.J., Smith, C.N., Parker-Thornburg, J.,
Swinton, P.G., Martin, J.F. and Behringer, R.R. (2014) Somatic mosaicism and
allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes.
Dev. Biol. 393, 3–9.
